- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 239/96 - Two oxygen atoms
Patent holdings for IPC class C07D 239/96
Total number of patents in this class: 135
10-year publication summary
|
13
|
16
|
6
|
4
|
8
|
10
|
15
|
11
|
5
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| IMPACT Therapeutics, Inc. | 34 |
10 |
| Shandong Cynda Chemical Co., Ltd. | 11 |
4 |
| Ajinomoto Co., Inc. | 2305 |
3 |
| Takeda Pharmaceutical Company Limited | 2702 |
3 |
| EA Pharma Co., Ltd. | 84 |
3 |
| Ludwig Institute for Cancer Research Ltd | 186 |
3 |
| Technion Research & Development Foundation Ltd. | 1204 |
3 |
| Impact Therapeutics (Shanghai), Inc | 47 |
3 |
| Novartis AG | 11041 |
2 |
| Glaxosmithkline Intellectual Property Development Limited | 736 |
2 |
| Consejo Superior de Investigaciones Cientificas | 900 |
2 |
| Emory University | 1606 |
2 |
| Gilead Sciences, Inc. | 2000 |
2 |
| Omeros Corporation | 303 |
2 |
| Shin Poong Pharmaceutical Co., Ltd. | 40 |
2 |
| Shionogi & Co., Ltd. | 877 |
2 |
| Southern Research Institute | 210 |
2 |
| Sutro Biopharma, Inc. | 165 |
2 |
| Rambam Med-Tech Ltd. | 82 |
2 |
| Sanofi | 3984 |
2 |
| Other owners | 79 |